u/Babette_CH

Reddit r/biotech_stocks
· tracked since Sep 2026
Calls
1
Win Rate
100.0%
return
+1.8%
Calls 1 3 Posts tracked · 1.0/day Posted today
Calls
7d 1
30d 1
90d 1
Win Rate 100% Long 1 Short 0
Win Rate
7d
30d
90d
Average Return +1.8% Long Return +1.8% Short Return -
Average Return
7d
30d
90d
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Sep 15
$1.70
+1.8%
Schrödinger AI validation makes LTRN's OMAI undervalued
The author contends that Bristol Myers Squibb deploying Schrödinger's AI co-scientist Bunsen and NEA/RA Capital's $55M investment into Tectora validate the scientific-AI model that Lantern is pursuing via OMAI/ZetaOmics. They argue Schrödinger is a blueprint for what OMAI could become, and given LTRN's tiny valuation, OMAI would not need to match Schrödinger for the impact to be substantial. The stated requirement is execution, with the risk that OMAI must prove pharma demand and raise external capital at a meaningful valuation.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions

u/Babette_CH has 1 trade ideas tracked on Buzzberg across 1 tickers since September 2026. Most covered: LTRN.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology